1. Guo, Hongguang, Liu, Hongliang, Wei, Jianhua, Wei, Qingyi, Liu, Zhensheng. 2013. Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck. In European journal of cancer (Oxford, England : 1990), 50, 582-92. doi:10.1016/j.ejca.2013.11.009. https://pubmed.ncbi.nlm.nih.gov/24295637/
2. Fukatsu, Asuki, Ishiguro, Futoshi, Tanaka, Ichidai, Hata, Yutaka, Sekido, Yoshitaka. 2013. RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer. In Lung cancer (Amsterdam, Netherlands), 83, 23-9. doi:10.1016/j.lungcan.2013.10.014. https://pubmed.ncbi.nlm.nih.gov/24246507/
3. Kudo, Takumi, Ikeda, Mitsunobu, Nishikawa, Misa, Nakagawa, Kentaro, Hata, Yutaka. 2012. The RASSF3 candidate tumor suppressor induces apoptosis and G1-S cell-cycle arrest via p53. In Cancer research, 72, 2901-11. doi:10.1158/0008-5472.CAN-12-0572. https://pubmed.ncbi.nlm.nih.gov/22593196/
4. Beveridge, Dianne J, Richardson, Kirsty L, Epis, Michael R, Woo, Andrew J, Leedman, Peter J. 2021. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. In Scientific reports, 11, 18003. doi:10.1038/s41598-021-97190-x. https://pubmed.ncbi.nlm.nih.gov/34504167/
5. Peng, Hu, Liu, Huanhai, Zhao, Shuwei, Fan, Jingping, Liao, Jianchun. 2013. Silencing of RASSF3 by DNA hypermethylation is associated with tumorigenesis in somatotroph adenomas. In PloS one, 8, e59024. doi:10.1371/journal.pone.0059024. https://pubmed.ncbi.nlm.nih.gov/23555615/
6. Zhong, Guoqiang, Lin, Yan, Huang, Zansong. 2023. Identification of a novel circRNA-miRNA-mRNA regulatory axis in hepatocellular carcinoma based on bioinformatics analysis. In Scientific reports, 13, 3728. doi:10.1038/s41598-023-30567-2. https://pubmed.ncbi.nlm.nih.gov/36878930/
智鼠故事 
